Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-5-8
|
pubmed:abstractText |
Primary adrenal insufficiency (Addison's disease) may initially present with cutaneous hyperpigmentation. Addison's disease, when associated with autoimmune thyroid disease and/or insulin-dependent diabetes mellitus, is referred to as polyglandular autoimmune syndrome type II. We present the case of a patient who initially was diagnosed as having Grave's disease and eventually Addison's disease due to persistent cutaneous hyperpigmentation, fatigue, weight loss, hypotension, hyponatremia, peripheral eosinophilia, and positive results of a synthetic corticotropin stimulation test. Addison's disease, polyglandular autoimmune syndrome type II, and cutaneous hyperpigmentation are reviewed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0011-4162
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-80
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:9040976-Anti-Inflammatory Agents,
pubmed-meshheading:9040976-Diagnosis, Differential,
pubmed-meshheading:9040976-Fludrocortisone,
pubmed-meshheading:9040976-Humans,
pubmed-meshheading:9040976-Hydrocortisone,
pubmed-meshheading:9040976-Hyperpigmentation,
pubmed-meshheading:9040976-Male,
pubmed-meshheading:9040976-Middle Aged,
pubmed-meshheading:9040976-Polyendocrinopathies, Autoimmune
|
pubmed:year |
1997
|
pubmed:articleTitle |
Cutaneous hyperpigmentation and polyglandular autoimmune syndrome type II.
|
pubmed:affiliation |
Department of Medicine, Darnall Army Community Hospital, Fort Hood, Texas, USA.
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|